Top

Archives of Osteoporosis

Published in:

Open Access 01-12-2022 | Obesity | Original Article

Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain)

Authors: Paula Hernández-Martínez, José M. Olmos, Javier Llorca, José L. Hernández, Jesús González-Macías

Published in: Archives of Osteoporosis | Issue 1/2022

Abstract

Summary

The associations of sarcopenia with osteoporosis or obesity have a very low prevalence. No trend towards an association between osteoporosis and sarcopenia is observed. Sarcopenia and obesity tend not to coincide, as if they were antagonistic disorders.

Purpose

To know (a) the prevalence in our region of sarcopenic osteoporosis (association of sarcopenia and osteoporosis (T-score < − 2.5)), sarcopenic obesity, and the association of osteoporosis, sarcopenia, and obesity; (b) the tendency of osteoporosis, sarcopenia, and obesity to associate with each other; and (c) the bone mineral density (BMD), the components of sarcopenia, and the prevalence of fragility fractures in these associations.

Methods

The study was performed in the Camargo cohort. Osteoporosis was diagnosed by DXA, sarcopenia by the EWGSOP-1 criteria, and obesity by body mass index (BMI) and fat percentage. Fractures were verified radiographically or by consulting the medical records.

Results

The prevalence of sarcopenic osteoporosis was 2.8% and the OR for this association 1.03 (p = 0.89). The prevalence of sarcopenic obesity by BMI was 1.4% and by fat percentage 5.9% (corresponding ORs: 0.18 (p < 0.0001) and 0.58 (p < 0.003) respectively). The prevalence of the association of osteoporosis, sarcopenia, and obesity was 0.0% when assessed by BMI and 0.8% when assessed by fat percentage. Patients with sarcopenic osteoporosis have less muscle mass and more fragility fractures than sarcopenic patients overall. In patients with sarcopenic obesity by fat percentage, muscle mass and strength, as well as physical performance, were similar to those of sarcopenic patients overall. Neither BMD nor fracture prevalence showed differences between patients with sarcopenic obesity and patients with sarcopenia or obesity in general.

Conclusion

Our study supports the idea that the prevalence of the mixed disorders studied is low. No significant association between osteoporosis and sarcopenia was found. Sarcopenia and obesity seem to tend to occur in different people, as if suffering from one of them hinders suffering from the other.

World Population Ageing 2019. Highlights. United Nations. Department of Economic and Social Affairs. Population Division https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf

Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia Lancet 393:2636–2646. https://doi.org/10.1016/S0140-6736(19)31138-9CrossRefPubMed

Rosenberg IH (2011) Sarcopenia: origins and clinical relevance. Clin Geriatr Med 27:337–339. https://doi.org/10.1016/j.cger.2011.03.003CrossRefPubMed

Cawthon PM (2018) Recent progress in sarcopenia research: a focus on operationalizing a definition of sarcopenia. Curr Osteoporos Rep 16:730–737. https://doi.org/10.1007/s11914-018-0484-2CrossRefPubMed

Moreland JD, Richardson JA, Goldsmith CH, Clase CM (2004) Muscle weakness and falls in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 52:1121–1129. https://doi.org/10.1111/j.1532-5415.2004.52310.xCrossRefPubMed

Compston JE, McClung MR, Leslie WD (2019) Osteoporosis Lancet 393:364–376. https://doi.org/10.1016/S0140-6736(18)32112-3CrossRefPubMed

Sirola J, Kroger H (2011) Similarities in acquired factors related to postmenopausal osteoporosis and sarcopenia. J Osteoporos 2011:536735. https://doi.org/10.4061/2011/536735CrossRefPubMedPubMedCentral

Tagliaferri C, Wittrant Y, Davicco MJ, Walrand S, Coxam V (2015) Muscle and bone, two interconnected tissues. Ageing Res Rev 21:55–70. https://doi.org/10.1016/j.arr.2015.03.002CrossRefPubMed

Hirschfeld HP, Kinsella R, Duque G (2017) Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int 28:2781–2790. https://doi.org/10.1007/s00198-017-4151-8CrossRefPubMed

10.

Scott D, Seibel M, Cumming R, Naganathan V, Blyth F, Le Couteur DG, Handelsman DJ, Waite LM, Hirani V (2019) Does combined osteopenia/osteoporosis and sarcopenia confer greater risk of falls and fracture than either condition alone in older men? The Concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci 74:827–834. https://doi.org/10.1093/gerona/gly162CrossRefPubMed

11.

Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, di Francesco V, Fantin F, Bissoli L, Bosello O (2005) Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond) 29:1011–1029. https://doi.org/10.1038/sj.ijo.0803005CrossRefPubMed

12.

Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V (2008) Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 18:388–395. https://doi.org/10.1016/j.numecd.2007.10.002CrossRefPubMed

13.

Ruesten A, Steffen A, Floegel A, Van der ADL, Masala G, Tjonneland A, Halkjaer J, Palli D, Wareham NJ, Loos RJF, Sørensen TIA, Boeing H (2011) Trend in obesity prevalence in European adult cohort populations during follow-up since 1996 and their predictions to 2015. PLoS ONE 6:e27455. https://doi.org/10.1371/journal.pone.0027455CrossRef

14.

Kelly OJ, Gilman JC, Boschiero D, Ilich JZ (2019) Osteosarcopenic Obesity: Current Knowledge. Revised Identification Criteria and Treatment Principles. Nutrients 11:747. https://doi.org/10.3390/nu11040747CrossRefPubMedPubMedCentral

15.

Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129

16.

Kanis JA, Melton L J, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141. https://doi.org/10.1002/jbmr.5650090802

17.

Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BE, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B, Delmas PD, Dequeker J, RagiEis S, Gennari C, Johnell O, Johnston CC Jr, Lau EM, Liberman UA, Lindsay R, Martin TJ, Masri B, Mautalen CA, Meunier PJ, Khaltaev N et al (1999) Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10:259–264. https://doi.org/10.1007/s001980050224CrossRefPubMed

18.

Hamdy RC, Petak SM, Lenchik L (2002) Which central dual X-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis? J Clin Densitom 5(Suppl):S11–S18. https://doi.org/10.1385/jcd:5:3s:s11CrossRefPubMed

19.

WHO (2000) Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation. WHO Tech Rep Series 894 Geneva, Switzerland. https://apps.who.int/iris/handle/10665/42330

20.

Donini LM, Busetto L, Bauer JM, Bischoff S, Boirie Y, Cederholm T, Cruz-Jentoft AJ, Dicker D, Frühbeck G, Giustina A, Gonzalez MC, Han HS, Heymsfield SB, Higashiguchi T, Laviano A, Lenzi A, Parrinello E, Poggiogalle E, Prado CM, Rodriguez JS, Rolland Y, Santini F, Siervo M, Tecilazich F, Vettor R, Yu J, Zamboni M, Barazzoni R (2020) Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr 39:2368–2388. https://doi.org/10.1016/j.clnu.2019.11.024CrossRefPubMed

21.

Cruz-Jentoft AJ, Baeyens JP, Jürgen M, Bauer JM, Boirie Y, Tommy Cederholm T Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M (2010) European Working Group on Sarcopenia in Older People Sarcopenia: European consensus on definition and diagnosis / Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423. https://doi.org/10.1093/ageing/afq034

22.

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C , Landi F, Rolland Y, Sayer AA , Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M (2019) Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31. https://doi.org/10.1093/ageing/afy169

23.

Hernandez JL, Olmos JM, Pariente E, Martinez J, Valero C, Garcia-Velasco P, Nan D, Llorca J, Gonzalez-Macias J (2010) Metabolic syndrome and bone metabolism. Menopause 17:955–961. https://doi.org/10.1097/gme.0b013e3181e39a15CrossRefPubMed

24.

Olmos JM, Hernandez JL, Garcia-Velasco P, Martinez J, Llorca J, Gonzalez-Macias J (2016) Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int 27:105–113. https://doi.org/10.1007/s00198-015-3219-6CrossRefPubMed

25.

Genant HK, Wu CY, van Kujik C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148. https://doi.org/10.1002/jbmr.5650080915CrossRefPubMed

26.

Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95:1851–1860. https://doi.org/10.1152/japplphysiol.00246.2003CrossRefPubMed

27.

Zhang Y, Hao Q, Ge M, Dong B (2018) Association of sarcopenia and fractures in community-dwelling older adults: a systematic review and meta-analysis of cohort studies. Osteoporos Int 29:1253–1262. https://doi.org/10.1007/s00198-018-4429-5CrossRefPubMed

28.

Mayhew AJ, Amog K, Phillips S, Parise G, McNicholas PD, de Souza RJ, Thabane L, Raina P (2019) The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing 48:48–56. https://doi.org/10.1093/ageing/afy106CrossRefPubMed

29.

Locquet M, Beaudart C, Bruyère O, Kanis JA, Delandsheere L, Reginster JY (2018) Bone health assessment in older people with or without muscle health impairment. Osteoporos Int 29:1057–1067. https://doi.org/10.1007/s00198-018-4384-1CrossRefPubMedPubMedCentral

30.

Nielsen BR, Abdulla J, Andersen HE, Schwarz P, Suetta C (2018) Sarcopenia and osteoporosis in older people: a systematic review and meta-analysis. Eur Geriatr Med 9:419–434. https://doi.org/10.1007/s41999-018-0079-6CrossRefPubMed

31.

Sjöblom S, Suuronen J, Rikkonen T, Honkanen R, Kröger H, Sirola J (2013) Maturitas Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia. Maturitas 75:175–180. https://doi.org/10.1016/j.maturitas2013.03.016CrossRefPubMed

32.

He H, Liu Y, Tian Q, Papasian CJ, Hu T, Deng HW (2016) Relationship of sarcopenia and body composition with osteoporosis. Osteoporos Int 27:473–482. https://doi.org/10.1007/s00198-015-3241-8CrossRefPubMed

33.

Kim IJ, Kang KY (2017) Low skeletal muscle mass is associated with the risk of low bone mineral density in urban dwelling premenopausal women. Calcif Tissue Int 101:581–592. https://doi.org/10.1007/s00223-017-0314-zCrossRefPubMed

34.

Locquet M, Beaudart C, Reginster JY, Bruyère O (2019) Association between the decline in muscle health and the decline in bone health in older individuals from the SarcoPhAge cohort. Calcif Tissue Int 104:273–284. https://doi.org/10.1007/s00223-018-0503-4CrossRefPubMed

35.

Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PlosOne 12:e0169548. https://doi.org/10.1371/journal.pone.0169548CrossRef

36.

Kemmler W, von Stengel S, Engelke K, Sieber C, Freiberger E (2016) Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study. Osteoporos Int 27:275–281. https://doi.org/10.1007/s00198-015-3303-yCrossRefPubMed

37.

Pal R, Bhadada SK, Aggarwal A, Singh T (2021) The prevalence of sarcopenic obesity in community-dwelling healthy Indian adults - the Sarcopenic Obesity-Chandigarh Urban Bone Epidemiological Study (SO-CUBES). Osteoporos Sarcopenia 7:24–29. https://doi.org/10.1016/j.afos.2020.12.003CrossRefPubMedPubMedCentral

38.

Genest F, Schneider M, Zehnder A, Lieberoth-Leden D, Seefried L (2021) Differential impact of osteoporosis, sarcopenia and obesity on physical performance in aging men. Endocr Connect 10:256–264. https://doi.org/10.1530/EC-20-0580CrossRefPubMedPubMedCentral

39.

Batsis JA, Mackenzie TA, Lopez-Jimenez F, Bartels SJ (2015) Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999–2004. Nutr Res 35:1031–1039. https://doi.org/10.1016/j.nutres.2015.09.003CrossRefPubMedPubMedCentral

40.

Chung JH, Hwang HJ, Shin HY, Han CH (2016) Association between sarcopenic obesity and bone mineral density in middle-aged and elderly Korean. Ann Nutr Metab 68:77–84. https://doi.org/10.1159/000442004CrossRefPubMed

41.

Ma Y, Zhang W, Han P, Kohzuki M, Guo Q (2020) Osteosarcopenic obesity associated with poor physical performance in the elderly Chinese Community. Clin Interv Aging 15:1343–1352. https://doi.org/10.2147/CIA.S257739CrossRefPubMedPubMedCentral

42.

Kolbaşı EN, Demirdağ F (2020) Prevalence of osteosarcopenic obesity in community-dwelling older adults: a cross-sectional retrospective study. Arch Osteoporos 15:166. https://doi.org/10.1007/s11657-020-00829-xCrossRefPubMed

43.

Ilich JZ, Inglis JE, Kelly OJ, McGee DL (2015) Osteosarcopenic obesity is associated with reduced handgrip strength, walking abilities, and balance in postmenopausal women. Osteoporos Int 26:2587–2595. https://doi.org/10.1007/s00198-015-3186-yCrossRefPubMed

44.

Szlejf C, Parra-Rodríguez L, Rosas-Carrasco O (2017) Osteosarcopenic obesity: prevalence and relation with frailty and physical performance in middle-aged and older women. J Am Med Dir Assoc 18:733.e1-733.e5. https://doi.org/10.1016/j.jamda.2017.02.023CrossRefPubMed

45.

Pang BWJ, Wee SL, Chen KK, Lau LK, Jabbar KA, Seah WT, Ng DHM, Tan QLL, Jagadish MU, Ng TP (2021) Coexistence of osteoporosis, sarcopenia and obesity in community-dwelling adults - the Yishun study. Osteoporos Sarcopenia 7:17–23. https://doi.org/10.1016/j.afos.2020.12.002CrossRefPubMedPubMedCentral

Title: Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain)
Authors: Paula Hernández-Martínez
José M. Olmos
Javier Llorca
José L. Hernández
Jesús González-Macías
Publication date: 01-12-2022
Publisher: Springer London
Keywords: Obesity
Obesity
Sarcopenia
Osteoporosis
Osteoporosis
Published in: Archives of Osteoporosis / Issue 1/2022
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-022-01146-1

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain)

Abstract

Summary

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Summary

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2022

An 11-year longitudinal analysis of refracture rates and public hospital service utilisation in Australia’s most populous state

Incidence of hip fracture in Saudi Arabia and the development of a FRAX model

Mobility and mortality outcomes among older individuals with hip fractures at a teaching hospital in Malaysia

Further evidence supports a much lower prevalence of radiographic osteoporotic vertebral fracture in Hong Kong Chinese women than in Italian Caucasian women

Prevalence and treatment of fragility fractures in Spanish primary care: PREFRAOS study

Patients undergoing surgical treatment for low-energy distal radius fractures are more likely to receive a referral and participate in a fracture liaison service program